Target intelligence / Profile preview

GUCY2C antisense RNA 1 (GUCY2C-AS1)

Target
GUCY2C-AS1
Molecular classification
Long non-coding RNA (lncRNA), Antisense RNA
01

Overview

GUCY2C antisense RNA 1 (GUCY2C-AS1) is a long non-coding RNA gene transcribed antisense to the GUCY2C locus. As an antisense RNA, it is thought to regulate the expression of the GUCY2C gene, although its specific regulatory mechanisms and functions remain understudied. GUCY2C-AS1 is classified within the lncRNA family and has been genetically associated with certain congenital gastrointestinal conditions such as meconium ileus and duodenal atresia. Like other antisense lncRNAs, it is likely to function in cis-regulation of neighboring genes, possibly influencing local chromatin structure or transcriptional activity, but no direct disease mechanisms or drug interactions have been ascribed to it[1][3][6]. No evidence currently supports GUCY2C-AS1 as a direct therapeutic target, receptor, or established biomarker. It should not be confused with the GUCY2C protein, which is a well-characterized transmembrane receptor with clinical relevance to gastrointestinal diseases and cancer[2][4][5][7].

02

Mechanism of action

not applicable. There is no direct mechanism of drug action for GUCY2C-AS1. However, in general, antisense RNAs regulate sense gene expression via RNA interference, transcriptional interference, or recruitment of chromatin remodeling complexes

03

Biological functions

Regulation of gene expression (likely regulation of its sense counterpart, GUCY2C)Possible involvement in chromatin organization or transcriptional interference (general properties of antisense lncRNAs)
04

Disease associations

Meconium ileusDuodenal atresia (based on genetic association studies)

Beyond the preview

Go deeper on GUCY2C antisense RNA 1 (GUCY2C-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on GUCY2C antisense RNA 1 (GUCY2C-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call